C Platat1, A Wagner, T Klumpp, B Schweitzer, C Simon. 1. Epidemiology of Cardiovascular Diseases and Cancers, Influence of Nutrition and Physical Inactivity, Louis Pasteur University of Strasbourg, Medical Faculty, 4 rue Kirschleger, F-67085, Strasbourg, Cedex, France.
Abstract
AIMS/HYPOTHESIS: Physical activity has beneficial effects on symptoms of the metabolic syndrome and low-grade inflammation in adults. These associations have rarely been studied in adolescents. Moreover, it has not been established whether they depend on adiposity, fat localisation and adipokines. SUBJECTS, MATERIALS AND METHODS: We used cross-sectional data of 640 12-year-old adolescents participating in the Intervention Centred on Adolescents' Physical Activity and Sedentary Behaviour Study (ICAPS). Weight, height, body fat mass and WHR were measured. Metabolic syndrome components, two inflammatory markers (IL-6 and C-reactive protein), plasma leptin, adiponectin and soluble TNF-alpha receptor 1 (sTNF-alpha R1) were determined. Insulin resistance was estimated by homeostasis model assessment (HOMA) and energy expenditure due to organised leisure-time physical activity (PAE) assessed by questionnaire. RESULTS: The metabolic syndrome was present in 5.8% of the adolescents. After adjustment for sex, sexual maturity and socio-economic status, a beneficial relationship between PAE and all metabolic syndrome features was found, but only the associations with HOMA and IL-6 were independent of body fat mass and WHR. Adjusted means from the lowest to the highest tertile of PAE were 1.99, 1.80 and 1.78 for HOMA (p=0.04), and 0.88, 0.69 and 0.70 pg/ml for IL-6 (p=0.02). PAE was inversely associated with leptin, independently of body fat mass and WHR (p<10(-2)), but not with adiponectin or sTNF-alpha R1. Further adjustment for adipokines did not change the relationships of PAE with HOMA and IL-6. CONCLUSIONS/ INTERPRETATION: In adolescents, physical activity is inversely related to HOMA and IL-6, independently of adiposity and fat localisation. These relationships are not accounted for by adipokines.
AIMS/HYPOTHESIS: Physical activity has beneficial effects on symptoms of the metabolic syndrome and low-grade inflammation in adults. These associations have rarely been studied in adolescents. Moreover, it has not been established whether they depend on adiposity, fat localisation and adipokines. SUBJECTS, MATERIALS AND METHODS: We used cross-sectional data of 640 12-year-old adolescents participating in the Intervention Centred on Adolescents' Physical Activity and Sedentary Behaviour Study (ICAPS). Weight, height, body fat mass and WHR were measured. Metabolic syndrome components, two inflammatory markers (IL-6 and C-reactive protein), plasma leptin, adiponectin and soluble TNF-alpha receptor 1 (sTNF-alpha R1) were determined. Insulin resistance was estimated by homeostasis model assessment (HOMA) and energy expenditure due to organised leisure-time physical activity (PAE) assessed by questionnaire. RESULTS: The metabolic syndrome was present in 5.8% of the adolescents. After adjustment for sex, sexual maturity and socio-economic status, a beneficial relationship between PAE and all metabolic syndrome features was found, but only the associations with HOMA and IL-6 were independent of body fat mass and WHR. Adjusted means from the lowest to the highest tertile of PAE were 1.99, 1.80 and 1.78 for HOMA (p=0.04), and 0.88, 0.69 and 0.70 pg/ml for IL-6 (p=0.02). PAE was inversely associated with leptin, independently of body fat mass and WHR (p<10(-2)), but not with adiponectin or sTNF-alpha R1. Further adjustment for adipokines did not change the relationships of PAE with HOMA and IL-6. CONCLUSIONS/ INTERPRETATION: In adolescents, physical activity is inversely related to HOMA and IL-6, independently of adiposity and fat localisation. These relationships are not accounted for by adipokines.
Authors: Paule Barbeau; Mark S Litaker; Kristy F Woods; Christian R Lemmon; Matthew C Humphries; Scott Owens; Bernard Gutin Journal: J Pediatr Date: 2002-09 Impact factor: 4.406
Authors: Paule Barbeau; Bernard Gutin; Mark S Litaker; Leigh T Ramsey; William E Cannady; Jerry Allison; Christian R Lemmon; Scott Owens Journal: Can J Appl Physiol Date: 2003-06
Authors: Sylvia E Badon; Alyson J Littman; Kwun Chuen Gary Chan; Michelle A Williams; Daniel A Enquobahrie Journal: Ann Epidemiol Date: 2017-10-13 Impact factor: 3.797
Authors: P Loprinzi; B Cardinal; C Crespo; G Brodowicz; R Andersen; E Sullivan; E Smit Journal: Scand J Med Sci Sports Date: 2011-08-03 Impact factor: 4.221
Authors: Ali Izadpanah; R James Barnard; Anna Jane E Almeda; Gayle C Baldwin; Sydney A Bridges; Erin R Shellman; Charles F Burant; Christian K Roberts Journal: Am J Physiol Endocrinol Metab Date: 2012-06-19 Impact factor: 4.310
Authors: Brenda W J H Penninx; Barbara J Nicklas; Anne B Newman; Tamara B Harris; Bret H Goodpaster; Suzanne Satterfield; Nathalie de Rekeneire; Kristine Yaffe; Marco Pahor; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-20 Impact factor: 6.053
Authors: Justin B Moore; Michael W Beets; Keith Brazendale; Steven N Blair; Russell R Pate; Lars B Andersen; Sigmund A Anderssen; Anders Grøntved; Pedro C Hallal; Katarzyna Kordas; Susi Kriemler; John J Reilly; Luis B Sardinha Journal: Med Sci Sports Exerc Date: 2017-07 Impact factor: 5.411
Authors: Brad S Metcalf; Alison N Jeffery; Joanne Hosking; Linda D Voss; Naveed Sattar; Terence J Wilkin Journal: Diabetes Care Date: 2008-11-25 Impact factor: 19.112
Authors: Gareth Knox; Julien S Baker; Bruce Davies; Susan Faulkner; Jaynie Rance; Anwen Rees; Kelly Morgan; Non Thomas Journal: BMC Public Health Date: 2009-12-15 Impact factor: 3.295